Publications

• 1. van den Brink NJM
  2. Pardow F
  3. Meesters LD
  4. van Vlijmen-Willems I
  5. Rodijk-Olthuis D
  6. Niehues H
  7. Jansen PAM
  8. Roelofs SH
  9. Brewer MG
  10. van den Bogaard EH
  11. Smits JPH
  Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.; The Journal of investigative dermatology. 2024 Apr 18.
• 1. Morgenstern AR
  2. Peterson LF
  3. Arnold KA
  4. Brewer MG
  Differentiation of keratinocytes or exposure to type 2 cytokines diminishes S. aureus internalization.; mSphere. 2024 Mar 19.
• 1. Moran MC
  2. Brewer MG
  3. Schlievert PM
  4. Beck LA
  S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection.; Microbiology spectrum. 2023 Sep 22.
• 1. Arnold KA
  2. Peterson LF
  3. Beck LA
  4. Brewer MG
  JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes.; International journal of molecular sciences; Vol 24(11). 2023 May 25.
• 1. Moran MC
  2. Chinchilli E
  3. Kenney HM
  4. Pope EM
  5. Scott G
  6. Brewer MG
  7. Beck LA
  Stage of Keratinocyte Differentiation is a Key Determinant of Viral Susceptibility in Human Skin.; The Journal of investigative dermatology. 2023 Mar 28.
• 1. Cognetti JS
  2. Moen MT
  3. Brewer MG
  4. Bryan MR
  5. Tice JD
  6. McGrath JL
  7. Miller BL
  A photonic biosensor-integrated tissue chip platform for real-time sensing of lung epithelial inflammatory markers.; Lab on a chip. 2023 Jan 03.
• 1. Brewer MG
  2. Monticelli SR
  3. Ward BM
  Monkeypox: Considerations as a New Pandemic Looms.; The Journal of investigative dermatology. 2022 Aug 23.
• 1. Moran MC
  2. Pope EM
  3. Brewer MG
  4. Beck LA
  Supply Chain Disruptions During COVID Pandemic Uncover Differences in Keratinocyte Culture Media.; JID innovations : skin science from molecules to population health. 2022 Aug 22.
• 1. Brewer MG
  2. Monticelli SR
  3. Moran MC
  4. Miller BL
  5. Beck LA
  6. Ward BM
  Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus.; Cells; Vol 11(8). 2022 Apr 14.
• 1. Monticelli SR
  2. Bryk P
  3. Brewer MG
  4. Aguilar HC
  5. Norbury CC
  6. Ward BM
  An increase in glycoprotein concentration on extracellular virions dramatically alters vaccinia virus infectivity and pathogenesis without impacting immunogenicity.; PLoS pathogens; Vol 17(12). 2021 Dec 28.
• 1. Moran MC
  2. Pandya RP
  3. Leffler KA
  4. Yoshida T
  5. Beck LA
  6. Brewer MG
  Characterization of Human Keratinocyte Cell Lines for Barrier Studies.; JID innovations; Vol 1(2). 2021 Jun.
• 1. Shi H
  2. Smits JPH
  3. van den Bogaard EH
  4. Brewer MG
  Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells.; The Journal of investigative dermatology; Vol 141(6), pp. 1375-1381.e1. 2021 Jun.
• 1. Moran MC
  2. Cahill MP
  3. Brewer MG
  4. Yoshida T
  5. Knowlden S
  6. Perez-Nazario N
  7. Schlievert PM
  8. Beck LA
  Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients.; mSphere; Vol 4(6). 2019 Dec 11.
• 1. Brewer MG
  2. Yoshida T
  3. Kuo FI
  4. Fridy S
  5. Beck LA
  6. De Benedetto A
  Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.; International journal of molecular sciences; Vol 20(17). 2019 Aug 21.
• 1. Brewer MG
  2. Anderson EA
  3. Pandya RP
  4. De Benedetto A
  5. Yoshida T
  6. Hilimire TA
  7. Martinez-Sobrido L
  8. Beck LA
  9. Miller BL
  Peptides Derived from the Tight Junction Protein, Claudin-1, Disrupt Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine.; The Journal of investigative dermatology. 2019 Aug 02.
• 1. Bryk P
  2. Brewer MG
  3. Ward BM
  Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.; Journal of virology; Vol 92(11). 2018 Jun 01.
• 1. Mathew E
  2. Zhu H
  3. Connelly SM
  4. Sullivan MA
  5. Brewer MG
  6. Piepenbrink MS
  7. Kobie JJ
  8. Dewhurst S
  9. Dumont ME
  Display of the HIV envelope protein at the yeast cell surface for immunogen development.; PloS one; Vol 13(10). 2018.
• 1. Brewer MG
  2. DiPiazza A
  3. Acklin J
  4. Feng C
  5. Sant AJ
  6. Dewhurst S
  Nanoparticles decorated with viral antigens are more immunogenic at low surface density.; Vaccine; Vol 35(5). 2017 Feb 01.
• 1. Mattiacio JL
  2. Brewer M
  3. Dewhurst S
  Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform.; Methods in molecular biology (Clifton, N.J.); Vol 1581. 2017.
• 1. Domm W
  2. Brewer M
  3. Baker SF
  4. Feng C
  5. Martínez-Sobrido L
  6. Treanor J
  7. Dewhurst S
  Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.; Journal of virological methods; Vol 197. 2014 Mar.
• 1. Alcéna DC
  2. Kobie JJ
  3. Kaminski DA
  4. Rosenberg AF
  5. Mattiacio JL
  6. Brewer M
  7. Dewhurst S
  8. Dykes C
  9. Jin X
  10. Keefer MC
  11. Sanz I
  9G4+ antibodies isolated from HIV-infected patients neutralize HIV-1 and have distinct autoreactivity profiles.; PloS one; Vol 8(12). 2013.
• 1. Swenson AK
  2. Higgins KE
  3. Brewer MG
  4. Brennessel WW
  5. Coleman MG
  Highly selective synthesis of tetra-substituted furans and cyclopropenes: copper(I)-catalyzed formal cycloadditions of internal aryl alkynes and diazoacetates.; Organic & biomolecular chemistry; Vol 10(37), pp. 7483-6. 2012 Aug 17.
• 1. Kobie JJ
  2. Alcena DC
  3. Zheng B
  4. Bryk P
  5. Mattiacio JL
  6. Brewer M
  7. Labranche C
  8. Young FM
  9. Dewhurst S
  10. Montefiori DC
  11. Rosenberg AF
  12. Feng C
  13. Jin X
  14. Keefer MC
  15. Sanz I
  9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.; PloS one; Vol 7(4). 2012.
• 1. Mattiacio J
  2. Walter S
  3. Brewer M
  4. Domm W
  5. Friedman AE
  6. Dewhurst S
  Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env.; Vaccine; Vol 29(14). 2011 Mar 21.